Things are starting to look REALLY interesting here:
● George Livery, Director of Strategy & Corporate at Swisse Wellness Group to become Executive Chairman
● Swisse is Australia’s top multivitamin brand when measured by sales - Company was purchased by Hong Kong listed, Chinese company Biostime (now H&H Group) in September 2015 for A$1.67 billion
● Mr Livery has over 25 years experience in senior executive roles domestically and internationally including 7 years at Swisse
● Mr Livery left Swisse/HH Group on 16 May 2018 and this will be the first (and currently only) public company directorship
● Remuneration geared towards equity in Bod with performance milestones linked to revenue and earnings – additional incentives included in the case of an approved and completed takeover bid
● Mr Livery will assist Bod in accessing the highest levels of domestic and international distribution channels, implement appropriate marketing initiatives, commence ambassador programs for key products and provide highly valuable strategic and corporate advice
● Provides strong validation for Bod’s portfolio of products and an extremely strong executive platform to launch into the next financial year and beyond
BDA Price at posting:
52.5¢ Sentiment: Buy Disclosure: Held
